Search

John Skoug Phones & Addresses

  • Osseo, WI
  • 251 Cater Ln, Libertyville, IL 60048 (847) 549-1741
  • 237 Appley Ave, Libertyville, IL 60048 (847) 549-1741
  • 9942 Wexford Dr, Portage, MI 49024 (269) 329-2670
  • Lane, IL
  • 227 Cliffwood Ave, Portage, MI 49002

Work

Position: Food Preparation and Serving Related Occupations

Education

Degree: High school graduate or higher

Public records

Vehicle Records

John Skoug

View page
Address:
251 Cater Ln, Libertyville, IL 60048
Phone:
(847) 549-1741
VIN:
1G1PJ5SC8C7172653
Make:
CHEVROLET
Model:
CRUZE
Year:
2012

Resumes

Resumes

John Skoug Photo 1

Owner

View page
Location:
251 Cater Ln, Libertyville, IL 60085
Industry:
Pharmaceuticals
Work:
Farmcmc
Owner

Abbvie Jan 1, 2013 - Apr 2019
Senior Director, Pharmaceutical Sciences

Abbott Dec 1, 2005 - Dec 2012
Director, Global Pharmaceutical Sciences

Pharmacia Pfizer Oct 2000 - Jul 2005
Director, Pharmaceutical Sciences Program Management

Pharmacia & Upjohn Pharmacia Feb 1997 - Oct 2000
Director, Physical Pharmacy
Education:
Purdue University Aug 1981 - May 1987
Doctorates, Doctor of Philosophy, Chemistry
University of Wisconsin - River Falls
Skills:
Drug Development
Pharmaceutical Industry
Drug Discovery
Analytical Chemistry
Gmp
Technology Transfer
John Skoug Photo 2

John Skoug

View page

Publications

Us Patents

Diffusion Layer Modulated Solids

View page
US Patent:
20050042291, Feb 24, 2005
Filed:
Jun 29, 2004
Appl. No.:
10/881712
Inventors:
Michael Hawley - Kalamazoo MI, US
Walter Morozowich - Kalamazoo MI, US
Michael Bergren - Portage MI, US
John Skoug - Portage MI, US
Phillip Nixon - Portage MI, US
John Heimlich - Portage MI, US
Ping Gao - Portage MI, US
International Classification:
A61K009/24
US Classification:
424473000
Abstract:
Diffusion layer modulated solids that include an excipient and a soluble salt of a poorly soluble, basic drug; a soluble salt of a poorly soluble, acidic drug; or a poorly soluble, non-ionizable drug are useful, for example, for improved delivery of drugs.

Controlled Release Dosage Form Having Improved Drug Release Properties

View page
US Patent:
20030152624, Aug 14, 2003
Filed:
Dec 19, 2002
Appl. No.:
10/325298
Inventors:
Dale Aldrich - Richland MI, US
Randy Wald - Portage MI, US
Anthony Hlinak - Lindenhurst IL, US
Rebanta Bandyopadhyay - Portage MI, US
Martin Coffey - Portage MI, US
Diane Goll - Portage MI, US
Ahmad Mazhary - Algonquin IL, US
Richard Meury - Kalamazoo MI, US
Brian Rohrs - Scotts MI, US
John Skoug - Portage MI, US
Stephen Secreast - Portage MI, US
Dennis Stelzer - Otsego MI, US
Jackie White - Portage MI, US
International Classification:
A61K031/137
A61K009/22
US Classification:
424/468000, 514/649000
Abstract:
Controlled release pharmaceutical compositions comprising tolterodine and a polymer-based release-controlling component and processes for preparing such compositions are provided. The compositions are useful in the treatment of overactive bladder and similar conditions.
John W Skoug from Osseo, WI, age ~66 Get Report